Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Ovarian Neoplasms

  Free Subscription


30.12.2018

1 Ann Oncol
1 BMC Cancer
2 Gynecol Oncol
1 Proc Natl Acad Sci U S A


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Oncol

  1. HUANG T, Tworoger SS, Willett WC, Stampfer MJ, et al
    Associations of early life and adulthood adiposity with risk of epithelial ovarian cancer.
    Ann Oncol. 2018 Dec 21. pii: 5255827. doi: 10.1093.
    PubMed     Text format     Abstract available


    BMC Cancer

  2. MCGUIRE WP, Penson RT, Gore M, Herraez AC, et al
    Randomized phase II study of the PDGFRalpha antibody olaratumab plus liposomal doxorubicin versus liposomal doxorubicin alone in patients with platinum-refractory or platinum-resistant advanced ovarian cancer.
    BMC Cancer. 2018;18:1292.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  3. RAUH-HAIN JA, Hidrue MK, Gaccione P, Melamed A, et al
    Variation in resource utilization associated with the surgical management of ovarian cancer.
    Gynecol Oncol. 2018 Dec 19. pii: S0090-8258(18)31513.
    PubMed     Text format     Abstract available

  4. MYSONA D, Pyrzak A, Purohit S, Zhi W, et al
    A combined score of clinical factors and serum proteins can predict time to recurrence in high grade serous ovarian cancer.
    Gynecol Oncol. 2018 Dec 18. pii: S0090-8258(18)31515.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  5. LI C, Bonazzoli E, Bellone S, Choi J, et al
    Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors.
    Proc Natl Acad Sci U S A. 2018 Dec 24. pii: 1814027116.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: